Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.

Saved in:
Bibliographic Details
Title: Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.
Authors: Subbiah, V.1 vsubbiah@mdanderson.org, Shen, T.1,2,3, Terzyan, S.S.1,4,5, Liu, X.1,2,3, Hu, X.2,3, Patel, K.P.6, Hu, M.7, Cabanillas, M.7, Behrang, A.8, Meric-Bernstam, F.1, Vo, P.T.T.2, Mooers, B.H.M.1,2,4,5 blaine-mooers@ouhsc.edu, Wu, J.1,2,3 jie-wu@ouhsc.edu
Source: Annals of Oncology. Feb2021, Vol. 32 Issue 2, p261-268. 8p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.10.599